Synthetic Biology Platforms
Codexis
by Codexis, Inc.
Engineered enzyme technology platform powering sustainable pharmaceutical synthesis and industrial biotransformations
Category
Synthetic Biology Platforms
Founded
2002
Headquarters
Redwood City, CA, USA
Overview
Codexis is a leading enzyme engineering company that uses its proprietary CodeEvolver directed evolution platform to develop highly optimized biocatalysts for pharmaceutical manufacturing, food and beverage production, and molecular diagnostics. CodeEvolver combines computational protein modeling with high-throughput screening to rapidly evolve enzymes with dramatically improved activity, selectivity, stability, and cost profiles compared to natural starting points, enabling biocatalytic synthesis routes that replace environmentally harmful chemical steps in drug manufacturing. Major pharmaceutical companies — including Pfizer, Merck, and Novartis — partner with Codexis to develop custom enzyme packages for API synthesis, enabling greener, more cost-effective manufacturing routes. Codexis-engineered enzymes have been used in the commercial manufacturing of sitagliptin (Januvia), islatravir, and multiple other drugs, and the company's biocatalysts are estimated to have contributed to the synthesis of billions of doses of pharmaceutical products. Codexis also provides molecular biology reagents and engineered enzymes to the life sciences research tools market. Codexis's differentiation is the maturity and commercial validation of its CodeEvolver platform — 20+ years of enzyme engineering experience has produced proprietary algorithms, protein engineering protocols, and a vast database of structure-activity relationships that enable faster and more predictable enzyme optimization than competitors. The company holds a strong patent portfolio on both evolved enzymes and the CodeEvolver process, and has structured licensing relationships that provide partners access to the platform in exchange for milestone and royalty payments. Recent pivots toward diagnostics enzyme supply and Pfizer's licensing of CodeEvolver technology demonstrate the platform's versatility beyond pharmaceutical synthesis.
Key Features
Metabolic Modeling
Genome-scale metabolic models predict optimal genetic modifications for target compound production.
Biosecurity Screening
Automated screening of synthetic DNA orders against regulated pathogen sequences.
Organism Tracking & IP
Track engineered organisms with digital provenance records and intellectual property documentation.
Automated Strain Engineering
High-throughput strain construction combining robotic assembly with ML-guided genetic design.
Metabolic Pathway Design
Computational design of biosynthetic pathways for production of target compounds in engineered organisms.
Pros & Cons
Pros
- +Proprietary strain libraries and genetic parts catalogs accelerate design-build-test-learn cycles
- +Bio-manufacturing partnerships enable commercial scale-up from prototype to production organisms
- +Foundry-scale automation processes thousands of genetic designs in parallel
- +Cell programming platform designs custom organisms for therapeutics, agriculture, and industrial biotechnology
- +Automated organism engineering combines high-throughput strain construction with ML-guided design
- +End-to-end platform from DNA design through fermentation optimization and process development
- +Metabolic modeling predicts optimal genetic modifications for target compound production
Cons
- −Scale-up from laboratory to commercial production introduces unpredictable biological challenges
- −Design-build-test-learn cycles still require weeks to months for complex organism engineering
- −High upfront investment in foundry automation infrastructure before generating meaningful results
- −Intellectual property landscape for genetic parts and engineered organisms is complex
Use Cases
Strain Engineering & Optimization
Automated organism engineering combining high-throughput strain construction with ML-guided metabolic design.
Biosynthetic Pathway Design
Computational design of metabolic pathways for production of target compounds in engineered organisms.
Fermentation Scale-Up
Data-driven optimization of fermentation conditions from lab-scale to commercial biomanufacturing.